Yüklüyor......
Recent Advances in Systemic Therapies for Advanced Hepatocellular Carcinoma
PURPOSE OF REVIEW: This paper aims to summarize the data of recently completed and key ongoing clinical trials of systemic agents for advanced hepatocellular carcinoma (aHCC). In particular, the review focuses on ongoing checkpoint inhibitor combination trials and promising studies combining tyrosin...
Kaydedildi:
| Yayımlandı: | Curr Hepatol Rep |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer US
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7848044/ https://ncbi.nlm.nih.gov/pubmed/33552839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11901-021-00560-2 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|